I share the same sentiment regarding Chiropractors. However, that is why they would be a good target for Actipatch. They are always trying to increase revenues in their clinics with bogus supplemental care (Vitamins, Herbs, devices etc..). Since they cannot prescribe, they are always looking for new gadgets to try on their desperate pain patients. Put a pilot rep in a major Metropolitan area and call on Chiropractors and other pain care specialists that cannot prescribe (and even those who can)..see what happens. That is of course if BIEL can get additional clearances (Back especially). See my previous post for further clarification. As for additional indications, lets get Migraine and full clearance approved FIRST. Why not treat depression and anxiety? I guess full clearance would allow a trial with virtually every disease state that potentially could respond to electroceutical stimulation. This is common for off lable use..even with pharmaceuticals. Neurontin was initially approved for seizures, then off lable use for fibromyalgia and even psychiatric disorders. Unmet disease states will try anything if there is a product FDA approved on the market for initial indications. That is where a territory rep could foster new ideas with very low risk. IMO
News 
Market Data 
Discover 
